Cargando…
Planning health care for patients with Graves’ orbitopathy
BACKGROUND: To describe disease parameters of patients with Graves’ orbitopathy in a tertiary referral center in order to plan health care resource allocations. To investigate whether the clinical activity and/or the severity of the disease can be used as a predictor of the duration of treatment. ME...
Autores principales: | Sasim, Inna V., Berendschot, Tos T. J. M., van Isterdael, Chantal, Mourits, Maarten P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491431/ https://www.ncbi.nlm.nih.gov/pubmed/18581132 http://dx.doi.org/10.1007/s00417-008-0842-3 |
Ejemplares similares
-
18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021) -
Relative selenium insufficiency is a risk factor for developing severe Graves’ orbitopathy: a case–control study
por: Lumyongsatien, Mingkwan, et al.
Publicado: (2021) -
Balancing orbital volume reduction and redistribution for a tailored surgical treatment in Graves’ ophthalmopathy
por: Costan, Victor Vlad, et al.
Publicado: (2020) -
Novel point-of-care biomarkers of the dry anophthalmic socket syndrome: tear film osmolarity and matrix metalloproteinase 9 immunoassay
por: Rokohl, Alexander C., et al.
Publicado: (2022) -
The use of HCT and/or ACE inhibitors significantly increases the risk of non-melanotic skin cancer in the periocular region
por: Mehlan, Juliane, et al.
Publicado: (2022)